Introduction
Extracellular pH (pH
e) becomes acidic due to excess cellular glycolysis. In the presence of oxygen, lactic acid is the main cause of extracellular acidification, a process called the “Warburg effect” or “aerobic glycolysis” [
1]. Because the expression of most glycolytic enzymes is driven by hypoxia inducible factor-1 (HIF-1), extracellular acidification is closely related to hypoxia [
1]. Among lactate anion/H
+ symporters, also known as monocarboxylate transporters (MCTs), the hypoxia-inducible subtype MCT4 is primarily responsible for the secretion of lactic acid. MCT4 exports lactate, thereby affecting the proliferation of tumor cells [
2]. An alternative major cause of extracellular acidity in tumor tissue results from the hydration of CO
2 by tumor carbonic anhydrase IX [
3,
4]. HIF-1 activation in tumors up-regulates angiogenesis and/or lymphangiogenesis. These newly formed vessels provide primary tumor cells the opportunity to disseminate through the circulation [
5]. Acidic pH
e also induces the production of vascular endothelial cell growth factor (VEGF)-A [
6], interleukin-8 (IL-8) [
7], and VEGF-C [
8] through an HIF-1 independent pathway. Thus, an acidic pH
e microenvironment, whether independent of, in addition to, or synergistically with hypoxia, may support the malignant phenotype of cancer cells and play a role in metastasis.
Tumor-derived acidic pH
e can act as a feed-back stimulator of a metastatic phenotype. Our investigations of the association of acidic pH
e with the metastasis-related activities of mouse B16 melanoma variants, including the induction of matrix metalloproteinase-9 (MMP-9) expression, found that MMP-9 induction correlated with the metastatic activity of B16 variants and the acceleration of tumor invasion through type IV collagen sheets [
9,
10]. Transient exposure to acidic pH
e resulted in a switch from an epithelial to a mesenchymal phenotype, called an epithelial-mesenchymal transition (EMT) [
11‐
13]. Transient acidic pH
e 5.9–6.8 was found to potentiate the invasive and metastatic activities of these cells [
8,
12,
14‐
19]. In vivo mapping of pH
e in mouse B16-F10 melanoma xenografts with CEST-MRI [
20] showed that the pH
e of most early stage tumors ranged between pH 6.0–6.2, whereas the pH
e of most late stages tumors ranged between pH 5.7–6.7, with 10% of the area of late stage tumors having a pH
e < 5.5. These findings suggested that primary tumors were continuously influenced by pH
e 6.0–6.2 over a long period and that adaptation of tumor cells to this pH
e range is an important step in tumor metastasis.
Because an acidic microenvironment can chronically affect tumor cells in vivo, studies are needed to evaluate the chronic effects of pH
e. Tumor cell lines have been subjected to chronic extracellular acidification and/or adaptation to pH
e 6.7 for 2 weeks to 3 months [
21‐
23]. We found that the growth rates of cells were equal at pH 6.8 and pH 7.4 and that these cells could grow at pH 6.5 after recovering from a transient decrease in proliferation rate. In vivo imaging showed that pH
e 6.2 could be attained [
20]. In this study, we established cells proliferating exponentially at pH 6.2 and investigated whether adaptation to acidic pH
e increased tumor metastatic activity and whether the metastatic phenotype could be sustained at neutral pH
e.
Discussion
Metastatic activity has been associated with the tumor microenvironment, which consists of growth factors, the extracellular matrix, hypoxia, and acidic pH
e. The acidic pH
e surrounding tumors is caused by the tumor cells’ secretion of lactic acid and CO
2. Imaging technology has shown that tumors surrounded by pH
e are heterogeneous, consisting of acid donor and recipient cells [
29]. This may be reflected in their relative use of MCT types, with donor cells mainly using MCT4 to secrete lactate/H
+ [
2] and recipient cells mainly using MCT1 to incorporate lactate/H
+ [
30]. Initially, we investigated the effect of transient acidic pH
e on metastatic phenotype [
9,
26,
31,
32]. However, metastasis is thought to be caused by the dissemination of cells from the primary tumor, with tumor cells being affected by the tumor microenvironment including acidic pH
e. This study therefore focused on the effects of adaptation to acidic pH
e especially on tumor invasion and metastasis. Transient acidification induces effective but reversible effects [
9,
33], called the “memory effect” [
33], which may be responsible for increased experimental metastasis induced by transient acidification [
33,
34]. This study showed that tumor cell adaptation to acidic pH
e resulted in a metastatic phenotype. The high invasive activity of acidic pH
e-adapted tumor cells was sustained through at least 28 serial passages (about 3 months) at neutral pH
e, suggesting that the sustained invasive phenotype of these cells was likely not due to a memory effect but rather to an acquired phenotype. Thus, the acidic pH
e-mediated acquisition of metastatic phenotype can likely be sustained in the circulation in vivo.
We also observed differences between cells exposed to transient acidification and those adapted to acidic pH
e. Although
Krt5 mRNA expression was higher in acidic pH
e-adapted LLCm1A than in LLCm1 cells, it was lower in the latter cells exposed to transient acidification. In contrast,
Trpm5 mRNA, which encodes a molecule involved in sensing acidic pH
e and whose overexpression in patients with melanoma and gastric cancer has been associated with shorter survival [
26], was not affected by transient acidification. Although transient exposure of cells to acidic pH
e-induced EMT [
11,
12,
35], acidic pH
e-adapted LLCm1A cells unexpectedly showed reduced expression of
Act2 mRNA, which encodes a mesenchymal marker, and increased expression of
Krt5 mRNA. Our working hypothesis was that cells of primary tumors affected for a long time by acidic microenvironments metastasize through the circulation. EMT is an important step, especially for dissemination of cells from primary tumors, whereas MET is involved in the establishment of secondary tumor formation [
36]. This study assessed the in vivo metastatic potential of tumor cells injected through the tail vein, an experimental lung metastasis model evaluating steps in secondary tumor formation. Therefore, this experimental design reflected a situation in which primary tumor cells that had survived and adapted to acidic pH intravasate into the circulation, which is at pH
e 7.4. The acquired metastatic potential of acidic pH
e-adapted tumor cells was sustained at physiological pH, with these cells playing an important role in secondary tumor formation through MET-like conversion.
Transient and chronic extracellular acidification have been reported to affect metabolic pathways through epigenetic alterations, including histone acetylation and DNA methylation [
18,
37‐
39]. Adaptation or, in this study, resistance to acidic pH
e may also be regulated by these epigenetic alterations. Because highly proliferative cells consume glucose to generate ATP, and deoxyribose from the pentose-phosphate pathway, adaptation to extracellular acidification resulted in an escape from glucose dependence [
37]. Cancer stem cells (CSC) and tumor initiating cells, which are resistant to drugs and divide asymmetrically, are thought to be the origin of tumor recurrence and metastasis [
40]. CSCs are likely affected by, but are not responsible for, extracellular acidification [
41], suggesting that cells adapted to acidic pH
e may have a partial CSC phenotype and may be a therapeutic target as much as CSCs [
42].
The number of passages of cultured cells has been reported to affect tumor phenotype. Serial long-term or late passage was found to increase the metastatic activity of rat mammary adenocarcinomas [
43], whereas serial passage of human pancreatic carcinomas had no effect on invasive activity [
44]. Late passage was found to increase metastatic activity but not invasion through Matrigel
® [
45], and late passage of human ovarian carcinoma cells increased MMP-9 but not MMP-2 expression [
46]. Moreover,
KRT5 mRNA expression was higher in early than in late passage cells of the human mammalian epithelial MCF10A cell line, with late passage cells having a more mesenchymal phenotype than early passage cells [
47], indicating that late passage decreased the stemness of human amnion mesenchymal cells [
48]. In the present study, LLCm1A cells were derived from parental LLCm1 cells.
These parental cells were serially passaged in our laboratory and showed a stable phenotype, as assessed by morphology, MMP production, in vitro invasiveness and experimental metastasis. These activities were not increased by serial passage, in contrast to previous findings [
12]. Moreover, tumor cell growth was extremely slow during adaptation to acid pH, but recovered after acidification, with adapted cells showing exponential growth without lag time just after seeding. Because a study of LLC cells found that the metastatic heterogeneity of tumors already pre-existed [
49], we evaluated the heterogeneity of MMP production, invasiveness and growth potential at acidic pH
e. Despite having growth potential at acidic pH
e with high MMP production, LLCm1 cell clone 4 did not have invasive activity, suggesting that the acquisition of invasive and metastatic ability is likely due not only to a simple effect of serial passage, but to adaptation to acidic pH
e. Because our experiments could not completely distinguish between simple clonal selection and adaptation to acidic pH
e, both remain possible. Our results showed, however, that acidic pH
e altered the tumor microenvironment, shifting tumor heterogeneity to the accumulation of a metastatic population. Because acidic pH
e was reported to induce the expression of sterol regulatory element-binding protein 2 (SREBP2) in pancreatic cancer cells [
18], lipid homeostasis may regulate tumor metastasis in acidic microenvironments.
In conclusion, these findings suggest that prolonged tumor cell acidification induced a sustained invasive phenotype through a mechanism differing from that resulting from transient exposure to acidic pHe.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.